| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.33 | 0.03 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.04 |